| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2002 | EP1165050A1 Methods for fine powder formation |
| 01/02/2002 | EP1165049A2 Agglomerates by crystallisation |
| 01/02/2002 | EP1165046A1 Propofol compositions containing preservative additives |
| 01/02/2002 | EP1165045A1 Propofol formulation with enhanced microbial characteristics |
| 01/02/2002 | EP1165044A2 High potency dihydroergotamine compositions |
| 01/02/2002 | EP1165043A1 Drinkable pharmaceutical solution |
| 01/02/2002 | EP1165042A1 Drinkable ibuprofen pharmaceutical suspension |
| 01/02/2002 | EP1165041A1 Antimicrobial wipes which provide improved immediate germ reduction |
| 01/02/2002 | EP1165039A2 Dermatological topical composition |
| 01/02/2002 | EP1165035A2 Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells |
| 01/02/2002 | EP1165033A1 Use of vitamin c or the like for stimulating skin cell synthesis |
| 01/02/2002 | EP1165032A1 Cosmetic and/or pharmaceutical preparations |
| 01/02/2002 | EP1165031A1 Resorcinol composition |
| 01/02/2002 | EP1165025A1 Compact hairspray product consisting of hairspray concentrate, container and fine spray pump with pre-pressurization |
| 01/02/2002 | EP1165013A2 Inhibitors of prenyl-protein transferase |
| 01/02/2002 | EP1164996A1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones |
| 01/02/2002 | EP1164994A1 Opioid agonist in a fast dispersing dosage form |
| 01/02/2002 | EP1164991A1 Gels formed by the interaction of poly(aldehyde) with various substances |
| 01/02/2002 | EP1164874A1 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and the use thereof for reducing transport through tight junctions |
| 01/02/2002 | EP1164865A1 Method for selectively altering body fat level, feed efficiency, or weight gain |
| 01/02/2002 | EP1164848A1 Compositions and methods for preventing and treating sexual dysfunctions |
| 01/02/2002 | EP1164846A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 01/02/2002 | EP1121930A4 Drug preparation "histochrome" for treating acute myocardial infarction and ischaemic heart diseases |
| 01/02/2002 | EP1112053A4 Organosilicone compositions for personal care |
| 01/02/2002 | EP1109789A4 Triptolide prodrugs having high aqueous solubility |
| 01/02/2002 | EP1001801B1 Product comprising at least a double stranded rna combined with at least an interferon for the treatment of viral hepatitis |
| 01/02/2002 | EP0983273B1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 01/02/2002 | EP0958307B1 O-sulfated bacterial polysaccharides |
| 01/02/2002 | EP0954314B1 Dosage forms for ameliorating male erectile dysfunction |
| 01/02/2002 | EP0932408B1 Pharmaceutical and cosmetic formulations with antimicrobial activity |
| 01/02/2002 | EP0912553B1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/02/2002 | EP0892801B1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 01/02/2002 | EP0877796A4 Compositions and methods for mediating cell cycle progression |
| 01/02/2002 | EP0873308B1 O-carbamoyl-phenylalaninol compounds and their pharmaceutically useful salts |
| 01/02/2002 | EP0871630B1 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO 3,4':4,5]FURO(3,2-b)PYRIDINE-6,8 7H]-DIONE DERIVATIVES FOR USE IN CONTROLLING ENDOPARASITES AND A METHOD OF PRODUCING SAID DERIVATIVES |
| 01/02/2002 | EP0785938B1 Fused pyrrolocarbazoles |
| 01/02/2002 | EP0764157B1 Benzopyrans and their use as therapeutic agents |
| 01/02/2002 | EP0745074B1 4-amino derivatives of mycophenolic acid with immunosuppressant activity |
| 01/02/2002 | EP0671414B1 Dermatan sulfate composition as antithrombotic |
| 01/02/2002 | EP0665751B1 Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
| 01/02/2002 | EP0600079B1 Oral 1alpha-hydroxyprevitamin d |
| 01/02/2002 | CN1329668A Polyketide synthase enzymes and recombinant DNA constructs therefor |
| 01/02/2002 | CN1329618A Nucleosides with anti-hepatitis B virus activity |
| 01/02/2002 | CN1329617A Hygromycin A derivatives as antibacterial agents |
| 01/02/2002 | CN1329616A Acylated benzylmal tosides as inhibitors of smooth muscle cell proliferaton |
| 01/02/2002 | CN1329613A New compounds |
| 01/02/2002 | CN1329610A Chromenone and chromanone derivatives as integrin inhibitors |
| 01/02/2002 | CN1329609A Tetrahydrobenza epine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
| 01/02/2002 | CN1329608A Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenediamine group |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/02/2002 | CN1329605A Benzofuran derivatives their preparation and use |
| 01/02/2002 | CN1329601A New benzimidazolone-benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 01/02/2002 | CN1329600A Method for control of arthropods in animals |
| 01/02/2002 | CN1329599A 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1329595A New processes for producing beta-alanine derivative |
| 01/02/2002 | CN1329594A Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/02/2002 | CN1329593A N-substituted 2-cyanopyrrolidines |
| 01/02/2002 | CN1329590A Therapeutic product and its use |
| 01/02/2002 | CN1329589A N-aralkylaminotetralins as ligands for neuroptide YY5 receptor |
| 01/02/2002 | CN1329508A Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 01/02/2002 | CN1329507A Topical compositions comprising ascomycins |
| 01/02/2002 | CN1329506A Formulation with an improved therapeutic range, cntainng nucleotide synthesis inhibitors |
| 01/02/2002 | CN1329505A Composition and method for treating allergic diseases |
| 01/02/2002 | CN1329498A Cancer treatment composition and method using natural plant essential oils |
| 01/02/2002 | CN1329497A Cmbination therapy to treat hepatitis b virus |
| 01/02/2002 | CN1329496A Methods and cmpositions for prevention of tolerance to medications |
| 01/02/2002 | CN1329495A Use of ibandronate for promoting osseointegration of endoprostheses |
| 01/02/2002 | CN1329494A Micronized eplerenone compositions |
| 01/02/2002 | CN1329493A Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 01/02/2002 | CN1329492A Remedial agent for erectile dysfunction |
| 01/02/2002 | CN1329491A Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 01/02/2002 | CN1329490A Composition and method for treating allergic diseases |
| 01/02/2002 | CN1329489A Methods and compositions for selective cancer chemotherapy |
| 01/02/2002 | CN1329488A Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 01/02/2002 | CN1329487A Dispersible compositions containing L-dopaethyl ester |
| 01/02/2002 | CN1329170A Preparation method of swine pancreatic island cell DNA and medicinal application for curing diabetes |
| 01/02/2002 | CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 01/02/2002 | CN1328851A Medicine for curing rheumatic heart disease |
| 01/02/2002 | CN1328840A Medicated bag for curing tussis |
| 01/02/2002 | CN1328836A Ointment for curing hemorrhoids |
| 01/02/2002 | CN1328825A Ass-hide glue cutting process |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/02/2002 | CN1328823A Medicine for curing disease of deficiency in attention |
| 01/02/2002 | CN1328822A Medicine for curing Parkinson's disease |
| 01/02/2002 | CN1328821A Medicine for curing psoriasis |
| 01/02/2002 | CN1328820A Application of calcium L-threonate for curing fracture |
| 01/02/2002 | CN1328815A Sunscreen compound containing basic component 4,4'-diarylbutadiene as uvioresistant light-filtering agent in cosmetics and medicine preparation |
| 01/02/2002 | CN1077109C S type 2-substituted hydroxy 2-indolidinylbutyric ester compounds and process for preparation thereof |
| 01/02/2002 | CN1077104C Palladium catalyzed ring closure of triazolyl tryptamine |
| 01/02/2002 | CN1077103C Chiral methyl phenyl oxazolidinones |
| 01/02/2002 | CN1076969C Preparation for substitution therapy containing at least one progestogen and at least one extrogen |
| 01/02/2002 | CN1076968C Use of benzo-thiophene compound for preparing medicine for inhibiting bone prosthesis degeneration |
| 01/02/2002 | CN1076967C Use of droloxifene for treatment of cardiovascular diseases |
| 01/02/2002 | CN1076966C Use of archin for preparing medicine for delaying chronic renal failure |
| 01/02/2002 | CN1076958C Stress regulator for animals |
| 01/01/2002 | WO2002089812A1 Composition for treating drug-induced constipation with 15-keto-prostaglandins |
| 01/01/2002 | US6335469 High purity (1R,2S,4R)-(-)-2-[(2′-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof |
| 01/01/2002 | US6335467 Intermediates for antiarrhythmia agents |
| 01/01/2002 | US6335465 Sterilized 5-aminolevulinic acid |